시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
임상시험 지원 서비스 시장 규모, 점유율, 성장 분석 : 서비스별, 단계별, 시험 디자인별, 적응증별, 스폰서별, 지역별 - 산업 예측(2025-2032년)
Clinical Trials Support Services Market Size, Share, and Growth Analysis, By Service, By Phase, By Study Design, By Indication, By Sponsor, By Region - Industry Forecast 2025-2032
상품코드 : 1677855
리서치사 : SkyQuest
발행일 : 2025년 03월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,692,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,998,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,304,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

임상시험 지원 서비스 2023년 시장 규모는 230억 달러로, 2024년 248억 4,000만 달러에서 2032년에는 459억 8,000만 달러로 확대하며, 예측 기간(2025-2032년)의 CAGR은 8.0%로 성장할 전망입니다.

임상시험 업계는 특히 COVID-19 이후 임상시험, 분석 설계, 지원 서비스에 중점을 두고 괄목할 만한 진화를 이루었습니다. 임상시험용 의약품의 확보 및 보관, 임상시험 시설의 안전 확보, 약물 투여량 계산, 키트 관리 등 필수적인 업무가 이 분야에서 중요한 역할을 하고 있습니다. 특히 2021년 COVID-19 백신 개발 이후 연기되었던 많은 임상시험이 재개되면서 신흥 국가 시장에서 증가하는 만성질환, 전염병, 열대성 질환에 대응하기 위한 혁신적인 의약품에 대한 긴급한 필요성도 부각되고 있습니다. 또한 가상 임상시험으로의 전환이 임상시험 지원 서비스 매출 성장의 주요 원동력으로 부상하고 있으며, 연구 회사들은 임상 연구 방법의 효율성을 높이기 위해 가상 기술 채택을 늘리고 있습니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

임상시험 지원 서비스 시장 규모 : 서비스별 & CAGR(2025-2032)

임상시험 지원 서비스 시장 규모 : 단계별 & CAGR(2025-2032)

임상시험 지원 서비스 시장 규모 : 시험 디자인별 & CAGR(2025-2032)

임상시험 지원 서비스 시장 규모 : 적응증별 & CAGR(2025-2032)

임상시험 지원 서비스 시장 규모 : 스폰서별 & CAGR(2025-2032)

임상시험 지원 서비스 시장 규모 : 지역별 & CAGR(2025-2032)

경쟁 정보

주요 기업 개요

결론과 제안

KSA
영문 목차

영문목차

Clinical Trials Support Services Market size was valued at USD 23.0 billion in 2023 and is poised to grow from USD 24.84 billion in 2024 to USD 45.98 billion by 2032, growing at a CAGR of 8.0% during the forecast period (2025-2032).

The clinical trials industry has witnessed significant evolution, particularly post-pandemic, with an emphasis on clinical testing, assay design, and support services. Essential operations such as securing and storing research medications, safeguarding trial sites, calculating drug dosages, and managing kits play a vital role in this domain. The resurgence of numerous postponed trials, particularly after the development of COVID-19 vaccines in 2021, has also highlighted the urgent need for innovative pharmaceuticals to address rising chronic, infectious, and tropical diseases in emerging markets. Additionally, the shift towards virtual clinical trials has emerged as a key driver of revenue growth in clinical trial support services, as research firms increasingly adopt virtual technologies to enhance the efficiency of their clinical research processes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Trials Support Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Trials Support Services Market Segments Analysis

Global Clinical Trials Support Services Market is segmented by Service, Phase, Study Design, Indication, Sponsor and region. Based on Service, the market is segmented into Administrative Staff, Clinical Trial Site Management, Data Management and Institutional Review Boards. Based on Phase, the market is segmented into Phase I, Phase II, Phase III and Phase IV. Based on Study Design, the market is segmented into Expanded Access, Interventional and Observational. Based on Indication, the market is segmented into Autoimmune or Inflammation, Cardiovascular, Diabetes and Oncology. Based on Sponsor, the market is segmented into Medical Devices and Pharmaceutical & Biopharmaceutical. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Clinical Trials Support Services Market

The growth of the Clinical Trials Support Services market is primarily driven by several key factors, including the increasing prevalence of infectious and chronic diseases, which necessitates extensive research efforts. Additionally, pharmaceutical companies are investing significantly in research and development, further fueling market expansion. The rise of contract research organizations (CROs) is also contributing to this trend, as they offer specialized expertise and resources for conducting clinical trials. Furthermore, the escalating demand for clinical trials in emerging markets is creating new opportunities, ultimately driving the overall growth and evolution of the Clinical Trials Support Services landscape.

Restraints in the Clinical Trials Support Services Market

The growth of the Clinical Trials Support Services market is hindered by insufficient medical infrastructure and advanced technological equipment. Moreover, strict regulations surrounding patient recruitment and the absence of robust management frameworks for the trials pose significant challenges to the market's overall development. However, there remains a promising opportunity for growth driven by the globalization of clinical trials and continuous advancements in technology resulting from ongoing research and development efforts. Addressing these constraints could pave the way for a more dynamic market environment, fostering innovation and improving the efficiency of clinical trial processes.

Market Trends of the Clinical Trials Support Services Market

The Clinical Trials Support Services market is poised for significant growth due to several key trends. The increasing demand for clinical trials in emerging nations, propelled by improved regulatory frameworks and healthcare infrastructure, is driving expansion. Additionally, rising research and development (R&D) investments from pharmaceutical companies, largely fueled by patent expirations, are escalating the need for efficient trial execution. The proliferation of contract research organizations (CROs) further enhances this trend, as they offer specialized services that streamline the trial process and reduce costs. Collectively, these factors indicate a robust and rapidly expanding global market for clinical trials support services.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Clinical Trials Support Services Market Size by Service & CAGR (2025-2032)

Global Clinical Trials Support Services Market Size by Phase & CAGR (2025-2032)

Global Clinical Trials Support Services Market Size by Study Design & CAGR (2025-2032)

Global Clinical Trials Support Services Market Size by Indication & CAGR (2025-2032)

Global Clinical Trials Support Services Market Size by Sponsor & CAGR (2025-2032)

Global Clinical Trials Support Services Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기